Please use this identifier to cite or link to this item:
https://doi.org/10.1021/ac401821d
DC Field | Value | |
---|---|---|
dc.title | Multiple reaction monitoring mass spectrometry for the discovery and quantification of o-glcnac-modified proteins | |
dc.contributor.author | Maury, J.J.P. | |
dc.contributor.author | Ng, D. | |
dc.contributor.author | Bi, X. | |
dc.contributor.author | Bardor, M. | |
dc.contributor.author | CHOO BOON HWA,ANDRE | |
dc.date.accessioned | 2014-10-08T09:45:49Z | |
dc.date.available | 2014-10-08T09:45:49Z | |
dc.date.issued | 2014-01-07 | |
dc.identifier.citation | Maury, J.J.P., Ng, D., Bi, X., Bardor, M., CHOO BOON HWA,ANDRE (2014-01-07). Multiple reaction monitoring mass spectrometry for the discovery and quantification of o-glcnac-modified proteins. Analytical Chemistry 86 (1) : 395-402. ScholarBank@NUS Repository. https://doi.org/10.1021/ac401821d | |
dc.identifier.issn | 00032700 | |
dc.identifier.uri | http://scholarbank.nus.edu.sg/handle/10635/87954 | |
dc.description.abstract | O-linked N-acetylglucosamine (O-GlcNAc) is a post-translational modification regulating proteins involved in a variety of cellular processes and diseases. Unfortunately, O-GlcNAc remains challenging to detect and quantify by shotgun mass spectrometry (MS) where it is time-consuming and tedious. Here, we investigate the potential of Multiple Reaction Monitoring Mass Spectrometry (MRM-MS), a targeted MS method, to detect and quantify native O-GlcNAc modified peptides without extensive labeling and enrichment. We report the ability of MRM-MS to detect a standard O-GlcNAcylated peptide and show that the method is robust to quantify the amount of O-GlcNAcylated peptide with a method detection limit of 3 fmol. In addition, when diluted by 100-fold in a trypsin-digested whole cell lysate, the O-GlcNAcylated peptide remains detectable. Next, we apply this strategy to study glycogen synthase kinase-3 beta (GSK-3β), a kinase able to compete with O-GlcNAc transferase and modify identical site on proteins. We demonstrate that GSK-3β is itself modified by O-GlcNAc in human embryonic stem cells (hESC). Indeed, by only using gel electrophoresis to grossly enrich GSK-3β from whole cell lysate, we discover by MRM-MS a novel O-GlcNAcylated GSK-3β peptide, bearing 3 potential O-GlcNAcylation sites. We confirm our finding by quantifying the increase of O-GlcNAcylation, following hESC treatment with an O-GlcNAc hydrolase inhibitor. This novel O-GlcNAcylation could potentially be involved in an autoinhibition mechanism. To the best of our knowledge, this is the first report utilizing MRM-MS to detect native O-GlcNAc modified peptides. This could potentially facilitate rapid discovery and quantification of new O-GlcNAcylated peptides/proteins. © 2013 American Chemical Society. | |
dc.description.uri | http://libproxy1.nus.edu.sg/login?url=http://dx.doi.org/10.1021/ac401821d | |
dc.source | Scopus | |
dc.type | Article | |
dc.contributor.department | BIOENGINEERING | |
dc.description.doi | 10.1021/ac401821d | |
dc.description.sourcetitle | Analytical Chemistry | |
dc.description.volume | 86 | |
dc.description.issue | 1 | |
dc.description.page | 395-402 | |
dc.description.coden | ANCHA | |
dc.identifier.isiut | 000329548700037 | |
Appears in Collections: | Staff Publications |
Show simple item record
Files in This Item:
There are no files associated with this item.
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.